Feb 13, 2025
Switching to DENARASE®: Regulatory considerations for Biopharmaceutical Manufacturing
c-LEcta GmbH, a leading biotechnology company, has released a new guidance document to support the...
read more
Sep 11, 2024
Highly efficient DNA removal in Viral Vector Manufacturing
In this presentation we will show you how we used our proprietary engineering platform ENESYZ® for...
read more
Jul 30, 2024
Upcoming Webinar: Salt-tolerant endonucleases and the benefits for viral vector manufacturing, and a comparison of two marketed enzymes
Tuesday 27th August 202408:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST Live30 webinars are...
read more
Mar 5, 2024
c-LEcta launches DENARASE® High Salt for enhanced process flexibility in Viral Vector Manufacturing
c-LEcta, a leading international supplier of enzymes for the biopharmaceutical industry announces...
read more
Sep 13, 2023
c-LEcta increases market presence in the USA
c-LEcta establishes a US warehouse for R&D-grade DENARASE® portfolio and partners with local...
read more
Jun 26, 2023
c-LEcta @ Bioprocessing Summit & BPI Boston
In August and September c-LEcta is presenting their DENARASE® portfolio: DENARASE® for research and...
read more
May 4, 2023
Accelerate the Manufacturing of Gene and Cell Therapies with GMP Enzymes from c-LEcta
During BPI US West in San Diego, our Head of Marketing Raphael Gübeli talked about recent trends...
read more
Apr 19, 2023
US FDA DMF Support for DENARASE® GMP-grade
c-LEcta successfully filed a Drug Master File (Type II) with the US FDA in 2021. We spoke with Dr....
read more
Mar 28, 2023
Kerry and c-LEcta enter agreement to market DENARASE® products
Kerry, a world leader in taste and nutrition, and c-LEcta, a leading biotechnology company in...
read more
Feb 14, 2023
BioProcess International US West, San Diego
From February 27 - March 2, 2023 the BPI US West will take place in San Diego. The BPI US West...
read more